Chronic treatment with cisplatin induces chemoresistance through the TIP60-mediated Fanconi anemia and homologous recombination repair pathways

Abstract The Fanconi anemia pathway in coordination with homologous recombination is essential to repair interstrand crosslinks (ICLs) caused by cisplatin. TIP60 belongs to the MYST family of acetyltransferases and is involved in DNA repair and regulation of gene transcription. Although the physical...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wen-Pin Su, Yen-Chih Ho, Cheng-Kuei Wu, Sen-Huei Hsu, Jia-Lin Shiu, Jheng-Cheng Huang, Song-Bin Chang, Wen-Tai Chiu, Jan-Jong Hung, Tsung-Lin Liu, Wei-Sheng Wu, Pei-Yu Wu, Wu-Chou Su, Jang-Yang Chang, Hungjiun Liaw
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/c4f9f089fbaf4a23a3f257a7acb65763
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c4f9f089fbaf4a23a3f257a7acb65763
record_format dspace
spelling oai:doaj.org-article:c4f9f089fbaf4a23a3f257a7acb657632021-12-02T15:05:56ZChronic treatment with cisplatin induces chemoresistance through the TIP60-mediated Fanconi anemia and homologous recombination repair pathways10.1038/s41598-017-04223-52045-2322https://doaj.org/article/c4f9f089fbaf4a23a3f257a7acb657632017-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-04223-5https://doaj.org/toc/2045-2322Abstract The Fanconi anemia pathway in coordination with homologous recombination is essential to repair interstrand crosslinks (ICLs) caused by cisplatin. TIP60 belongs to the MYST family of acetyltransferases and is involved in DNA repair and regulation of gene transcription. Although the physical interaction between the TIP60 and FANCD2 proteins has been identified that is critical for ICL repair, it is still elusive whether TIP60 regulates the expression of FA and HR genes. In this study, we found that the chemoresistant nasopharyngeal carcinoma cells, derived from chronic treatment of cisplatin, show elevated expression of TIP60. Furthermore, TIP60 binds to the promoters of FANCD2 and BRCA1 by using the chromatin immunoprecipitation experiments and promote the expression of FANCD2 and BRCA1. Importantly, the depletion of TIP60 significantly reduces sister chromatid exchange, a measurement of HR efficiency. The similar results were also shown in the FNACD2-, and BRCA1-deficient cells. Additionally, these TIP60-deficient cells encounter more frequent stalled forks, as well as more DNA double-strand breaks resulting from the collapse of stalled forks. Taken together, our results suggest that TIP60 promotes the expression of FA and HR genes that are important for ICL repair and the chemoresistant phenotype under chronic treatment with cisplatin.Wen-Pin SuYen-Chih HoCheng-Kuei WuSen-Huei HsuJia-Lin ShiuJheng-Cheng HuangSong-Bin ChangWen-Tai ChiuJan-Jong HungTsung-Lin LiuWei-Sheng WuPei-Yu WuWu-Chou SuJang-Yang ChangHungjiun LiawNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-15 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Wen-Pin Su
Yen-Chih Ho
Cheng-Kuei Wu
Sen-Huei Hsu
Jia-Lin Shiu
Jheng-Cheng Huang
Song-Bin Chang
Wen-Tai Chiu
Jan-Jong Hung
Tsung-Lin Liu
Wei-Sheng Wu
Pei-Yu Wu
Wu-Chou Su
Jang-Yang Chang
Hungjiun Liaw
Chronic treatment with cisplatin induces chemoresistance through the TIP60-mediated Fanconi anemia and homologous recombination repair pathways
description Abstract The Fanconi anemia pathway in coordination with homologous recombination is essential to repair interstrand crosslinks (ICLs) caused by cisplatin. TIP60 belongs to the MYST family of acetyltransferases and is involved in DNA repair and regulation of gene transcription. Although the physical interaction between the TIP60 and FANCD2 proteins has been identified that is critical for ICL repair, it is still elusive whether TIP60 regulates the expression of FA and HR genes. In this study, we found that the chemoresistant nasopharyngeal carcinoma cells, derived from chronic treatment of cisplatin, show elevated expression of TIP60. Furthermore, TIP60 binds to the promoters of FANCD2 and BRCA1 by using the chromatin immunoprecipitation experiments and promote the expression of FANCD2 and BRCA1. Importantly, the depletion of TIP60 significantly reduces sister chromatid exchange, a measurement of HR efficiency. The similar results were also shown in the FNACD2-, and BRCA1-deficient cells. Additionally, these TIP60-deficient cells encounter more frequent stalled forks, as well as more DNA double-strand breaks resulting from the collapse of stalled forks. Taken together, our results suggest that TIP60 promotes the expression of FA and HR genes that are important for ICL repair and the chemoresistant phenotype under chronic treatment with cisplatin.
format article
author Wen-Pin Su
Yen-Chih Ho
Cheng-Kuei Wu
Sen-Huei Hsu
Jia-Lin Shiu
Jheng-Cheng Huang
Song-Bin Chang
Wen-Tai Chiu
Jan-Jong Hung
Tsung-Lin Liu
Wei-Sheng Wu
Pei-Yu Wu
Wu-Chou Su
Jang-Yang Chang
Hungjiun Liaw
author_facet Wen-Pin Su
Yen-Chih Ho
Cheng-Kuei Wu
Sen-Huei Hsu
Jia-Lin Shiu
Jheng-Cheng Huang
Song-Bin Chang
Wen-Tai Chiu
Jan-Jong Hung
Tsung-Lin Liu
Wei-Sheng Wu
Pei-Yu Wu
Wu-Chou Su
Jang-Yang Chang
Hungjiun Liaw
author_sort Wen-Pin Su
title Chronic treatment with cisplatin induces chemoresistance through the TIP60-mediated Fanconi anemia and homologous recombination repair pathways
title_short Chronic treatment with cisplatin induces chemoresistance through the TIP60-mediated Fanconi anemia and homologous recombination repair pathways
title_full Chronic treatment with cisplatin induces chemoresistance through the TIP60-mediated Fanconi anemia and homologous recombination repair pathways
title_fullStr Chronic treatment with cisplatin induces chemoresistance through the TIP60-mediated Fanconi anemia and homologous recombination repair pathways
title_full_unstemmed Chronic treatment with cisplatin induces chemoresistance through the TIP60-mediated Fanconi anemia and homologous recombination repair pathways
title_sort chronic treatment with cisplatin induces chemoresistance through the tip60-mediated fanconi anemia and homologous recombination repair pathways
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/c4f9f089fbaf4a23a3f257a7acb65763
work_keys_str_mv AT wenpinsu chronictreatmentwithcisplatininduceschemoresistancethroughthetip60mediatedfanconianemiaandhomologousrecombinationrepairpathways
AT yenchihho chronictreatmentwithcisplatininduceschemoresistancethroughthetip60mediatedfanconianemiaandhomologousrecombinationrepairpathways
AT chengkueiwu chronictreatmentwithcisplatininduceschemoresistancethroughthetip60mediatedfanconianemiaandhomologousrecombinationrepairpathways
AT senhueihsu chronictreatmentwithcisplatininduceschemoresistancethroughthetip60mediatedfanconianemiaandhomologousrecombinationrepairpathways
AT jialinshiu chronictreatmentwithcisplatininduceschemoresistancethroughthetip60mediatedfanconianemiaandhomologousrecombinationrepairpathways
AT jhengchenghuang chronictreatmentwithcisplatininduceschemoresistancethroughthetip60mediatedfanconianemiaandhomologousrecombinationrepairpathways
AT songbinchang chronictreatmentwithcisplatininduceschemoresistancethroughthetip60mediatedfanconianemiaandhomologousrecombinationrepairpathways
AT wentaichiu chronictreatmentwithcisplatininduceschemoresistancethroughthetip60mediatedfanconianemiaandhomologousrecombinationrepairpathways
AT janjonghung chronictreatmentwithcisplatininduceschemoresistancethroughthetip60mediatedfanconianemiaandhomologousrecombinationrepairpathways
AT tsunglinliu chronictreatmentwithcisplatininduceschemoresistancethroughthetip60mediatedfanconianemiaandhomologousrecombinationrepairpathways
AT weishengwu chronictreatmentwithcisplatininduceschemoresistancethroughthetip60mediatedfanconianemiaandhomologousrecombinationrepairpathways
AT peiyuwu chronictreatmentwithcisplatininduceschemoresistancethroughthetip60mediatedfanconianemiaandhomologousrecombinationrepairpathways
AT wuchousu chronictreatmentwithcisplatininduceschemoresistancethroughthetip60mediatedfanconianemiaandhomologousrecombinationrepairpathways
AT jangyangchang chronictreatmentwithcisplatininduceschemoresistancethroughthetip60mediatedfanconianemiaandhomologousrecombinationrepairpathways
AT hungjiunliaw chronictreatmentwithcisplatininduceschemoresistancethroughthetip60mediatedfanconianemiaandhomologousrecombinationrepairpathways
_version_ 1718388670193467392